In children born at high altitude, lung development is affected by hypoxia, which can lead to pulmonary hypertension and right ventricular failure. Animal models of postnatal, transient, hypoxia ...

Cardiovascular outcomes show increased complications for patients facing gastrointestinal procedures with elevated pulmonary pressure. A link to this article will be included in this email. SAN ...

Dr. Tom Walsh, DVM, CCAT, CCRP, MBA, had a successful career in telecommunications but always knew his true calling was helping animals. Deciding to pursue that passion, he became a veterinarian and ...

Add Yahoo as a preferred source to see more of our stories on Google. If there are two things The Pitt has proven it excels at, it's tugging on our heartstrings and introducing us to horrifying new ...

If there are two things The Pitt has proven it excels at, it's tugging on our heartstrings and introducing us to horrifying new medical maladies. This week's episode managed to do both when the ...

Idiopathic pulmonary arterial hypertension (PAH) is a term used to describe PAH with an unknown cause. Some drugs and toxins damage lung arteries, which could lead to PAH. Up to 20% of people with PAH ...

Recently, I was asked what I know about pulmonary hypertension and before I answered, “nothing,” I asked my good friend Google what it was. Medlineplus.gov, gave me a good description. They say that ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIR™ ...

Pulmonary hypertension is a serious condition where there is abnormally high pressure in the blood vessels of the lungs. Oxygen-poor blood returning to the heart from all body organs and tissues ...

ACEi therapy initiated in the 5 years prior to IPF diagnosis was independently linked to lower all-cause mortality, suggesting ACEi might act as a disease-modifying agent. Angiotensin-converting ...